Activate: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with pyruvate kinase deficiency who are not regularly transfused

Authors
Category Primary study
ConferenceHemaSphere
Year 2021
This article has no abstract
Epistemonikos ID: 298b547b9f34ca81ad3b5bfe0a7ce1af74d45051
First added on: Apr 30, 2026